Medical Weight Loss Programs

---

Zepbound (tirzepatide) is a prescription, once‑weekly injectable for chronic weight management and metabolic control. As a dual GIP and GLP‑1 receptor agonist, it suppresses appetite, improves glycemic control, and produces significant, sustained weight loss.

Foundayo® (orforglipron) is an FDA‑approved, once‑daily oral GLP‑1 for adults with obesity or excess weight. It mimics GLP‑1 to reduce appetite, increase fullness, and slow digestion; it can be taken anytime with or without food, and trials show meaningful weight loss plus improvements in waist circumference, cholesterol, and blood pressure.

Contrave is a once‑daily, prescription weight‑management pill that pairs naltrexone (an opioid antagonist) with bupropion (an aminoketone antidepressant) to target brain pathways involved in appetite and cravings. When combined with diet and exercise, Contrave can help adults with obesity—or adults who are overweight with at least one weight‑related comorbidity—lose weight and maintain weight loss. 

Wegovy (Semaglutide) Injections decrease your appetite and cravings and help you reach your weight loss goals!  Semaglutide is a GLP-1 agonist. GLP-1 works to increase insulin levels by activating cells in the pancreas. It also triggers hormone release to delay the emptying of the stomach and curbs appetite. 

The FDA-approved Wegovy® pill is the first and only oral GLP-1 medication for weight loss in adults. Taken once daily, it offers the same proven benefits as injectable semaglutide, helping people with obesity or weight-related health conditions lose weight and keep it off. 

Qsymia combines phentermine and topiramate extended‑release to help adults (and pediatric patients ≥12 years per label) with obesity or overweight plus weight‑related comorbidities lose weight when used with a reduced‑calorie diet and increased physical activity.